Rebecca Kammer

Dr. Kammer has over two decades of experience in academia, low-vision patient care, clinician education, endpoint development, and professional consulting. She is considered a world-renowned expert in low-vision models of patient care and has conducted cutting-edge clinical trial research in retinitis pigmentosa (RP) and other retinal dystrophies.

Prior to joining jCyte, Dr. Kammer established and led the Low Vision Rehabilitation Service in the Department of Ophthalmology at the UCI Health Gavin Herbert Eye Institute, where she remains an Adjunct Professor of Ophthalmology. In addition, she has been consulting for companies as a leading authority in clinical low-vision research for the last decade. For RP and other future low vision clinical studies, Dr. Kammer has helped jCyte develop and validate its novel Low Luminance Mobility Test (LLMT), with recent validation work on this instrument presented at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. She has also used her extensive clinical experience in age-related macular degeneration to help companies develop and explore the effectiveness of potential therapies.

Dr. Kammer holds a Bachelor’s degree in Optical Engineering from the University of LaVerne, a Doctor of Optometry degree from the Southern California College of Optometry, and a Ph.D. in Higher Education from Azusa Pacific University.